bd 1047 has been researched along with fura-2 in 1 studies
| Studies (bd 1047) | Trials (bd 1047) | Recent Studies (post-2010) (bd 1047) | Studies (fura-2) | Trials (fura-2) | Recent Studies (post-2010) (fura-2) |
|---|---|---|---|---|---|
| 118 | 0 | 54 | 4,362 | 12 | 291 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akopova, I; Clark, AF; Daudt, DR; Ma, HY; Mueller, BH; Park, Y; Stankowska, DL; Yorio, T | 1 |
1 other study(ies) available for bd 1047 and fura-2
| Article | Year |
|---|---|
Sigma-1 receptor stimulation attenuates calcium influx through activated L-type Voltage Gated Calcium Channels in purified retinal ganglion cells.
Topics: Animals; Animals, Newborn; Blotting, Western; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Signaling; Cells, Cultured; Ethylenediamines; Fluorescent Antibody Technique, Indirect; Fura-2; Microscopy, Fluorescence; Pentazocine; Phenazocine; Rats; Rats, Sprague-Dawley; Receptors, sigma; Retinal Ganglion Cells; Sigma-1 Receptor; Verapamil | 2013 |